Schizophrenia: The broken P300 and beyond

Judith M. Ford

Psychophysiology · 1999 · 421 citations · 103 references

Concepts

TL;DR

Schizophrenia is frequently misunderstood as non‑biological, yet self‑report diagnosis and reduced P300 amplitude—along with other ERP changes—provide consistent biological evidence of the disease. The study aims to ground schizophrenia diagnosis and symptoms in biological evidence through psychophysiological research. P300 amplitude is both a state and trait marker that remains reduced even in remission, tracks symptom changes, and correlates with negative symptoms, attentional decline, and gray‑matter volume loss.

Abstract

Many of the social, economic, and political problems facing people with schizophrenia are due to a misconception in the community that schizophrenia is not a biologically based disease but a myth. Because the diagnosis is based on self-reported symptoms, it is difficult for many people to acknowledge that schizophrenia is real. One goal of psychophysiological research has been to anchor both diagnosis and symptoms in biological reality. Reduction of the amplitude of the P300 component of the event-related potential (ERP) is the most replicable biological marker of the disease. Data are presented suggesting that P300 is both a state and a trait marker of the disease and may be sensitive to the progressive/degenerative course of the disease. Although the P300 tracks changes in clinical symptoms, it remains reduced even in patients in relative remission. P300 amplitude reduction is related to enduring negative symptoms, waning of attention, and gray matter volume deficits. ERP components other than P300 can also manifest the biological reality of various symptoms of the disease.

References

103